4.36
                                            Schlusskurs vom Vortag:
              $4.32
            Offen:
              $4.37
            24-Stunden-Volumen:
                1.13M
            Relative Volume:
              0.97
            Marktkapitalisierung:
                $261.08M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-40.33M
            KGV:
              -2.4358
            EPS:
                -1.79
            Netto-Cashflow:
                $-39.53M
            1W Leistung:
              +13.84%
            1M Leistung:
              +53.52%
            6M Leistung:
                +31.72%
            1J Leistung:
              -17.74%
            Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Firmenname
                  
                      Eledon Pharmaceuticals Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      949-238-8090
                    
                Adresse
                  
                      19800 MACARTHUR BLVD., IRVINE
                    
                Vergleichen Sie ELDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ELDN
                            
                             
                        Eledon Pharmaceuticals Inc 
                           | 
                    4.36 | 258.69M | 0 | -40.33M | -39.53M | -1.79 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2025-01-28 | Eingeleitet | Guggenheim | Buy | 
| 2022-05-13 | Fortgesetzt | Cantor Fitzgerald | Overweight | 
| 2021-03-23 | Eingeleitet | Cantor Fitzgerald | Overweight | 
Eledon Pharmaceuticals Inc Aktie (ELDN) Neueste Nachrichten
How Eledon Pharmaceuticals Inc. (2TK) stock valuation compares with sector2025 Market WrapUp & Safe Entry Point Identification - newser.com
Published on: 2025-11-03 08:17:43 - newser.com
Market reaction to Eledon Pharmaceuticals Inc.’s recent news2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock attractive post correctionSwing Trade & Risk Managed Investment Strategies - newser.com
Real time scanner hits for Eledon Pharmaceuticals Inc. explainedQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Using AI based signals to follow Eledon Pharmaceuticals Inc.Weekly Investment Report & Verified Short-Term Trading Plans - newser.com
Will Eledon Pharmaceuticals Inc. (2TK) stock beat revenue estimates2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Eledon Pharmaceuticals Inc. stock momentum explained2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Visual trend scoring systems applied to Eledon Pharmaceuticals Inc.Weekly Trade Recap & Entry Point Confirmation Alerts - newser.com
Can Eledon Pharmaceuticals Inc. recover in the next quarterProfit Target & Verified Stock Trade Ideas - newser.com
Why Eledon Pharmaceuticals Inc. (2TK) stock stays on buy listsTrade Volume Report & Short-Term High Return Ideas - newser.com
Why Eledon Pharmaceuticals Inc. (2TK) stock could be top winnerDay Trade & Capital Protection Trade Alerts - newser.com
Will Eledon Pharmaceuticals Inc. stock gain from lower inflation2025 Top Gainers & High Accuracy Swing Trade Signals - newser.com
Why analysts remain bullish on Eledon Pharmaceuticals Inc. stockCPI Data & Daily Profit Maximizing Tips - newser.com
Eledon Pharmaceuticals Inc. stock daily chart insights2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
How to build a dashboard for Eledon Pharmaceuticals Inc. stockTrade Volume Summary & Short-Term High Return Ideas - newser.com
Can Eledon Pharmaceuticals Inc. (2TK) stock double in coming yearsGap Down & Long-Term Investment Growth Plans - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock supported by strong fundamentalsBull Run & Target Return Focused Stock Picks - newser.com
What dividend safety rating applies to Eledon Pharmaceuticals Inc. (2TK) stockMarket Volume Summary & Community Consensus Stock Picks - newser.com
Will breakout in Eledon Pharmaceuticals Inc. lead to full recoveryJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
Is Eledon Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Short Interest & High Conviction Trade Alerts - newser.com
Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 47.4% - MarketBeat
Published on: 2025-11-01 03:53:10 - newser.com
Published on: 2025-10-31 05:05:04 - newser.com
Is this a good reentry point in Eledon Pharmaceuticals Inc.2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Eledon Pharmaceuticals’ AT 1501: A Promising Kidney Transplant Study Update - TipRanks
Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):